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Abstract
Background: Catheter ablation for atrial fibrillation is a clinically established treatment by now 
while success rate varies between 60%  and 85%. Interventional treatment of atrial fibrillation is 
still  a challenging   technique  associated  with   a  long  procedure  time  and  risk  of  major 
complications in up to 6 % of treated patients. The aim of this study was to investigate the 
predictive value of plasma brain natriuretic peptide (BNP) in patients undergoing pulmonary 
vein isolation concerning stable sinus rhythm after ablation.                                                       
Methods: In 68 consecutive patients with atrial fibrillation  (AF) and normal left ventricular 
ejection fraction, BNP was measured at baseline before pulmonary vein isolation (PVI). All 
patients received a 7-days-holter monitoring 3 months after radiofrequency (RF) ablation in 
order   to   detect   recurrent   AF   episodes.                                                                   
Results: 48 patients with paroxysmal and 20 patients with persistent AF were enrolled. Baseline 
BNP was significantly higher in patients with persistent AF compared to patients with 
paroxysmal AF (145,5 pg/ml vs. 84,4 pg/ml; p<0,05). 3 months after PVI 38 patients (79,1%) 
with paroxysmal AF had a stable sinus rhythm documented on 7-days-holter monitoring, where 
as in 10 patients (20,9%) AF episodes were detected. Patients with a successful PVI showed  
significantly lower BNP plasma levels at baseline compared to patients with AF recurrrence 
(68,7 pg/ml vs. 144,1 pg/ml; p<0,05). In patients with persistent AF 55% (11 cases) had no 
recurrence of AF at 3 months 7-days holter and in 9 patients (45%) AF recurred. BNP plasma 
levels at baseline were lower in patients with stable sinusrhythm after 3 months compared to the 
group of recurrent AF (105,8 pg/ml vs. 193,3 pg/ml; p=0,11).                                   
Conclusion:  Patients with AF and low preprocedural BNP plasma levels showed a better 
outcome after PVI. Thus BNP may be helpful in patient selection for a successful treatment of 
AF   by   PVI.                                                                                                  
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Introduction
Pulmonary vein isolation (PVI) has been established as an effective tool in the treatment of drug 
refractory atrial fibrillation (AF). However PVI is still associated with long procedure duration 
and remains a challenging technique; furthermore extended left atrial ablation always contains 
the risk of major complication like stroke or pericardial tamponade. In consideration of these 
procedure specific aspects and a success rate of 60 to 85% [1,2], it seems to be crucial to assure 
an optimized patient selection. The purpose of this study was to investigate the predictive value 
of plasma brain natriuretic peptide (BNP) for a successfull PVI in patients with AF and normal 
left ventricular ejection fraction.                                                                                 
Material and Methods                                                                                                 
Patient Characteristics                                                                                            
The study population was selected from 68 consecutive symptomatic AF patients - 53 men, (28 
to 70 years), 48 with paroxysmal AF, and 20 with persistent AF. No patient had structural heart 
disease. All patients showed a normal left ventricular ejection fraction of greater than 55% 
applying echocardiographic criteria. Mean duration of atrial fibrillation was 3,8 years (8 months 
to 6 years). In 39 (58%) patients left atrial (LA) had a normal volume of <20cm2, in 18 (26%) 
patients LA was slightly enlarged (20 to 25 cm2), and in 11 (16%) patients LA volume was 
measured with to be ≥25 cm2. All patients provided written informed consent and the study was 
approved by the institutional review board.                                                                                         
Electrophysiological study and PVI procedure                                                                         
Right femoral venous access was obtained and a multipolar electrode catheter was introduced 
into the distal coronary sinus. After transseptal catheterization a 4mm tip deflectable catheter 
(Navistar, Biosense Webster) was advanced into the left atrium and a 3-dimensional shell 
representing the left atrium was constructed by using an electroanatomical mapping system 
(CARTO,   Biosense   Webster).   A   CT   image   of   the   left   atrium   was   integrated   using   a 
commercially available software (CARTOMERGE, Biosense Webster). Left atrial ablation was 
performed to encircle the left- and right sided pulmonary veins, with additional lines at the left 
atrial roof and the mitral isthmus in patients with persistent atrial fibrillation. Radiofrequency 
energy was delivered at a maximum power output of 25 - 35 W and target temperature of 55 °C. 
At the target sites RF energy was applied until maximum local electrogram amplitude decreased 
by >50% or to <0.1 mV. PV isolation was confirmed by using a LASSO catheter positioned 
inside the isolated PV.                                                                                               
Measurement of plasma BNP                                                                                                     
BNP level were obtained from the antecubital bein in the supine position one day before 
scheduled PVI. BNP level was determined using a chemi-luminescent immunoassay for human 
BNP (Roche Diagnostics, Mannheim, Germany). The reference value of plasma BNP was <100 
pg/dl.
Statistical   analysis                                                                                  
All data analysis was performed using the SigmaStat for Windows version 3.0 software. Data 
are expressed as medians, comparisons of the continous variables between the groups were 
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 9 (5): 241-246 (2009)Dong-In Shin, Thomas Deneke, Eduard Gorr, Helge Anders, Kathrin Buenz,                 243 
Marcus Paesler, Marc Horlitz, “Predicting Successful Pulmonary Vein Isolation In Patients 
With Atrial Fibrillation By Brain Natriuretic Peptide Plasma Levels” 
analyzed using Student's t-test or ANOVA, as appropriate. Statistical significance was selected 
as   a   value   of   p<0.05.                                                                                    
Results
Pulmonary vein isolation and follow up                                                                                 
Successful isolation of all pumonary veins was performed in all 68 patients (48 patients with 
paroxysmal AF, 20 patients with persistent AF). After three months all patients (100%) received 
a 7-days-holter monitoring. 38 (79,1%) patients with paroxysmal AF had stable sinus rhythm 
without any antiarrhythmic medication, while in 10 patients (20,9%) a recurrence of AF or the 
appearence of a left atrial tachycardia due to the ablation could be observed. In the group of 
patients with persistent AF 11 (55%) patients showed no recurrence of AF while in 9 patients 
(45%) paroxysmal or persistent AF could be detected.                                           
BNP   plasma   level                                                                                
BNP plasma levels in patients with paroxysmal AF were normal at baseline with 84,4 pg/ml. In 
contrast in patients with persistent AF BNP at baseline was significanly higher with 145,5 pg/ml 
(p<0.05) and is shown in Figure 1. Patients with paroxysmal AF and recurrence of AF after PVI 
showed significantly higher BNP plasma levels at baseline (144,1 pg/ml) compared to 68,7 
pg/ml (p<0.05) in patients with stable sinus rhythm as shown in Figure 2.  In the group of 
patients with persistent AF successfully treated patients had lower BNP levels with 105,8 pg/ml 
at baseline versus 193,3 pg/ml in patients with recurrent AF (p=0.11) as shown in Figure 3. 
Patients characteristics concerning age, duration of paroxysmal / persistent AF and left atrial 
volume showed no significant differences in both groups of patients with normal baseline BNP 
levels <100pg/ml or elevated levels >100pg/ml as shown in Table 1. 
Figure 1: BNP in patients with paroxysmal and persistent AF. BNP plasma levels before PVI were elevated in 
patients with persistent AF compared to patients with paroxysmal AF significantly.
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Figure 2:  BNP in paroxysmal AF patients grouped by PVI success. Patients with paroxysmal AF and stable 
sinusrhythm after PVI  showed significant lower BNP levels at baseline compared to patients with recurrent AF. 
Figure 3: BNP in persistent AF patients grouped by PVI success. In patients with persistent AF and successful PVI 
plasma levels of BNP at basline were lower than in patients with recurrent AF. 
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Table 1: Patient characteristics in both groups with  baseline BNP plasma levels <100pg/ml and >100pg/ml 
showing no statistical differences.
Discussion
Cardiac natriuretic peptides like BNP play an important role in the regulation of volume 
hemostasis. Studied mainly as a marker of congestive heart failure in structural heart disease [3,4] 
its diagnostic potential in patients with recurrent arrhythmias like AF remains unclear. Several 
studies have shown that even in patients with normal left ventricular ejection fraction and without 
clinical signs of congestive heart failure, BNP levels can be elevated due to an atrial overload and 
atrial remodelling caused by AF [5,6]. In our study all patients with AF were free of systolic left 
ventricular dysfunction or structual heart disease. However in patients with persistent AF BNP 
levels were significantly higher probably due to a higher grade of AF burden. Treatment of AF 
can be very challenging since the participation of triggering factors and substrate changes of the 
left atrium are not fully understood. Since ablation strategies for the treatment of AF have been 
introduced [7] the number of patients who have been treated by ablation has raised continously, 
especially in patients with symptomatic paroxysmal AF. Therefore left atrial ablation therapy of 
AF remains a complex ablation procedure associated with both procedural risks for the patients 
and challenging efforts for the electrophysiologist. Regarding the major complications of stroke, 
pericardial tamponade or oesophagus fistula and the consumption of time and material, the 
effectiveness of patient selection has to be improved, especially when considering success rates of 
only 70%. Besides established prognostic parameters for successful restoration of sinus rhythm in 
patients with AF like age, atrial size or duration of AF, we have demonstrated that BNP is a  
predictor of successful PV isolation in patients with paroxysmal AF. Although we could not prove 
the same predictive value of BNP in patients with persistent AF statistically, a tendency could be 
shown suggesting that BNP can also be used as predictor for successful PVI in patients with 
persistent AF.                                                                                                           
Conclusions
BNP is a predictor for successful PV isolation in patients with AF and should be determined 
routinely before an ablation procedure. It should be integrated in the process of patient selection 
for   ablation   of   atrial   fibrillation.                                                                      
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Study limitations                                                                              
Although all patients in this study  showed a normal systolic left ventricular function, we did not 
consider the possibility of a diastolic dysfunction which can contribute to an increased BNP level 
as well.  Due to the small number of cases included in this study the statistical analysis is limited, 
thus a trial with a larger cohort of patients is necessary to confirm our hypothesis, that BNP 
plasma levels are a feasible predictor of a succesful AF ablation procedure.                             
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